Bioavailability of vitamin B12 using a small-volume nebulizer ophthalmic drug delivery system

Clinical and Experimental Ophthalmology

Volumn 33, Issue 4, 2005, Pages 402-407

  Kahn, Monte ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ophthalmic drug delivery; Small volume nebulizer; Vitamin B12

Indexed keywords

CAMPHOR; CYANOCOBALAMIN; MENTHOL; OASIS EYE DROPS; EYE DROPS;

AQUEOUS HUMOR; ARTICLE; CATARACT; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG PENETRATION; DRUG TISSUE LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; NEBULIZER; PREOPERATIVE EVALUATION; RANDOMIZED CONTROLLED TRIAL; ABSORPTION; AEROSOL; BIOAVAILABILITY; LENS IMPLANTATION; METABOLISM;

ABSORPTION; AEROSOLS; AQUEOUS HUMOR; BIOLOGICAL AVAILABILITY; CATARACT EXTRACTION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG DELIVERY SYSTEMS; HUMANS; LENS IMPLANTATION, INTRAOCULAR; NEBULIZERS AND VAPORIZERS; OPHTHALMIC SOLUTIONS; VITAMIN B 12;

EID: 26944463100     PISSN: 14426404     EISSN: 14429071     Source Type: Journal    
DOI: 10.1111/j.1442-9071.2005.01030.x     Document Type: Article

References (19)

1. Zimmerman TJ. What's new for the medical therapy of glaucoma? Ann Ophthalmol 1978; 10: 627-8.
2. Kahn M, Sheu M. Cyanocobalamin as an indicator for titrating the bioavailability of an amphoteric drug delivery system. Invest Ophthalmol Vis Sci 1999; 40: 441, S83.
3. Tonjum AM, Green K. Quantitative study of fluorescein iontophoresis through the cornea. Am J Ophthalmol 1971; 71: 1328-32.
4. Summers WK, Reich TC. Delirium after cataract surgery: Review and two cases. Am J Psychiatry 1979; 136: 386-91.
5. Charles NC, Steiner GC. Ganciclovir intraocular implant a clinicopathologic study. Ophthalmology 1996; 103: 416-21.
6. Sall K, Stevenson OD, Mundorf TK, Reis BL, the CsA Phase 3 Study Group. Two multicenter randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. Ophthalmology; 107: 631-9.
7. Chrai SS, Makoid MC, Eriksen SP, Robinson JR. Drop size and initial dosing frequency problems of topically applied ophthalmic drugs. J Pharm Sci 1974; 63: 333-8.
8. Foulds WS, Chisholm FA, Steward JB, Wilson TM. The optic neuropathy of pernicious anemia. Arch Ophthalmol 1969; 82: 427-32.
9. Mauger TF, Craig EL. Havener's Ocular Pharmacology, 6th edn. St Louis: Mosby, 1994; 445, 514.
10. Jereb AF. Deutsches Patentamt. DE 3514724, A1, 3. 1fd, Nr. 85 162, 1985.
11. Grant WM. Toxicology of the Eye, 2nd edn. Springfield: Charles C Thomas Publisher, 1974; 226, 644.
12. O'Brien CS, Swan KC. Carbaminoyl choline chloride in the treatment of glaucoma simplex. AMA Arch Ophthalmol 1942; 27: 453.
13. Leopold IH. Local toxic effect of detergents on ocular structures. AMA Arch Ophthalmol 1945; 34: 99.
14. Cottrell GP, Surkin HB. Pharmacology for Respiratory Care Practitioners. Pennsylvania: FA Davis Co, 1995; 26.
15. Fraunfelder FT, Meyer SM. Drug-Induced Ocular Side Effects and Drug Interactions, 3rd edn. Philadelphia: Lea & Febiger, 1989; 238, 311, 318, 468.
16. Schoenwald RD. Ocular drug delivery pharmacokinetic consideration. Clin Pharmacokinet 1990; 18: 255-69.
17. Yagihshi S, Tokui A, Kashiwamura S, Takagi S, Imamura K. In vivo effect of methylcobalamin on the peripheral nerve structure in streptozotocin diabetic rats. Horm Metab Res 1982; 14: 10-13.
18. 12 - light and electron microscopy findings of the saphenous nerve in the rabbit. Neurochirugia 1990; 33: 113-21.
19. 12 (cobalamin) in the rat central nervous system. J Neuropathol Exp Neurol 2000; 59: 808-14.